查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1702264

失眠市场规模、份额、趋势及预测（按治疗类型、药物类别、配销通路和地区），2025 年至 2033 年

Insomnia Market Size, Share, Trends and Forecast by Therapy Type, Drug Class, Distribution Channel, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 150 Pages | 商品交期: 2-3个工作天内

价格

2024 年全球失眠市场规模价值 53.4 亿美元。展望未来， IMARC Group估计到 2033 年市场规模将达到 67.8 亿美元，2025-2033 年期间的复合年增长率为 2.55%。北美目前占据市场主导地位，到 2024 年将占据超过 36.4% 的显着市场。现代生活方式和压力导致的盛行率不断上升、诊断技术的进步提高了准确性、对新疗法的深入研究、医疗保健支出的增加、数位健康解决方案的整合、策略性产业合作以及消费者对非药物治疗的偏好日益增长是推动市场成长的一些因素。除此之外，先进的医疗保健、高睡眠障碍盛行率以及创新治疗方法的采用进一步增加了失眠市场的份额。

失眠是一种睡眠障碍，它会降低能量水平并影响个人的情绪、健康、工作表现和整体生活品质。其常见原因包括压力、长途旅行、繁忙的工作日程、不良的睡眠习惯、暴饮暴食以及过量摄取尼古丁、咖啡因和酒精。它也可能与精神健康障碍有关，例如创伤后压力症候群，以及使用抗忧郁药物治疗气喘或血压以及使用非处方药 (OTC) 来缓解疼痛、过敏和感冒。其治疗方案目前在全球范围内均有提供，例如认知行为疗法 (CBT)、非处方助眠剂以及处方药如 Eszopiclone 和 Ramelteon。

失眠市场趋势：

冠状病毒病（COVID-19）大流行为人们的生活带来了前所未有的变化，包括社会隔离以及无数的工作挑战和家庭义务。这是一个重大的压力事件，影响了数百万人的睡眠模式并促进了市场的成长。此外，慢性疼痛、癌症、糖尿病、心臟病、气喘、胃食道逆流 (GERD)、甲状腺功能亢进、帕金森氏症和阿兹海默症等疾病通常与失眠有关。因此，患有这些疾病的人数不断增加，推动了对失眠药物的需求。除此之外，月经週期和更年期期间的荷尔蒙变化可能会导致失眠的风险，这也促进了市场的成长。此外，由于睡眠模式、活动和健康状况的改变以及处方药使用量的增加会增加老年人失眠的可能性，全球老年人口的增长正在催化对失眠医疗的需求。此外，预计对预防、检测、治疗和管理失眠的新疗法、干预措施和测试的投资增加将推动市场发展。

本报告回答的关键问题

  • 失眠市场到底有多大？失眠市场未来前景如何？
  • 推动失眠市场发展的关键因素有哪些？
  • 哪个地区占失眠市场占有率最大？
  • 全球失眠市场领先的公司有哪些？

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 次要来源
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

  • 概述
  • 主要行业趋势

第五章：全球失眠市场

  • 市场概览
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依治疗类型

  • 非药物治疗
    • 关键部分
      • 催眠疗法
      • 认知行为疗法
      • 医疗器材
      • 其他的
  • 药物治疗
    • 关键部分
      • 处方助眠剂
      • 非处方助眠药

第七章：市场区隔：依药品类别

  • 抗忧郁药
  • 褪黑激素拮抗剂
  • 苯二氮平类药物
  • 非苯二氮平类药物
  • 食慾素拮抗剂
  • 其他的

第八章：市场区隔：按配销通路

  • 医院药房
  • 零售药局
  • 药局
  • 网路药局

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场区隔：依国家

第十章：SWOT分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Astellas Pharma Inc.
    • Aurobindo Pharma Limited
    • Biocodex
    • Eisai Co. Ltd.
    • Mallinckrodt Pharmaceuticals
    • Merck & Co. Inc.
    • Neurim Pharmaceuticals Inc.
    • Pfizer Inc.
    • Sanofi SA
    • Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.)
    • Takeda Pharmaceutical Company Limited
    • Vanda Pharmaceuticals Inc.
Product Code: SR112025A6148

The global insomnia market size was valued at USD 5.34 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 6.78 Billion by 2033, exhibiting a CAGR of 2.55% during 2025-2033. North America currently dominates the market, holding a significant market share of over 36.4% in 2024. Increasing prevalence due to modern lifestyles and stress, advancements in diagnostic technologies enhancing accuracy, robust research into novel therapies, rising healthcare expenditures, integration of digital health solutions, strategic industry collaborations, and growing consumer preference for non-pharmacological treatments are some of the factors bolstering the market growth. In addition to this, advanced healthcare, high sleep disorder prevalence, and adoption of innovative treatments are further increasing the insomnia market share.

Insomnia is a sleep disorder that can lower energy levels and affect the mood, health, work performance, and overall life quality of an individual. Its common causes include stress, long travels, hectic work schedules, poor sleep habits, binge eating, and excessive consumption of nicotine, caffeine, and alcohol. It can also be associated with mental health disorders, such as post-traumatic stress, and the use of drugs like antidepressants for asthma or blood pressure and over-the-counter (OTC) for pain relief, allergy, and cold. Its treatment options, such as cognitive-behavioral therapy (CBT), OTC sleep aids, and prescription medications like Eszopiclone and Ramelteon, are currently available worldwide.

Insomnia Market Trends:

The coronavirus disease (COVID-19) pandemic generated unprecedented changes in lives, including social isolation and innumerable work challenges and family obligations. This acts as a major stressful event that impacted the sleep patterns of millions and strengthened the market growth. Moreover, medical conditions, such as chronic pain, cancer, diabetes, heart disease, asthma, gastroesophageal reflux disease (GERD), overactive thyroid, Parkinson's disease, and Alzheimer's disease, are usually linked with insomnia. Hence, the increasing number of individuals suffering from these ailments is driving the demand for insomnia medications. Apart from this, hormonal shifts during the menstrual cycle and menopause can lead to the risk of developing insomnia, which is contributing to the market growth. In addition, as changes in sleep patterns, activity, and health and the rising use of prescription drugs can increase the chance of insomnia among older people, the growing geriatric population globally is catalyzing the demand for insomnia medical treatment. Furthermore, increasing investments in testing new treatments, interventions, and tests to prevent, detect, treat, and manage insomnia are anticipated to drive the market.

Key Market Segmentation:

Breakup by Therapy Type:

  • Non-Pharmacological Therapy
  • Hypnotherapy
  • Cognitive Behavioral Therapy
  • Medical Devices
  • Others
  • Pharmacological Therapy
  • Prescription Sleep Aids
  • Over-The-Counter Sleep Aids

Breakup by Drug Class:

  • Antidepressants
  • Melatonin Antagonist
  • Benzodiazepines
  • Nonbenzodiazepines
  • Orexin Antagonist
  • Others

Breakup by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Online Pharmacies

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Astellas Pharma Inc., Aurobindo Pharma Limited, Biocodex, Eisai Co. Ltd., Mallinckrodt Pharmaceuticals, Merck & Co. Inc., Neurim Pharmaceuticals Inc., Pfizer Inc., Sanofi S.A., Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.), Takeda Pharmaceutical Company Limited and Vanda Pharmaceuticals Inc.

Key Questions Answered in This Report

  • 1.How big is the insomnia market?
  • 2.What is the future outlook of insomnia market?
  • 3.What are the key factors driving the insomnia market?
  • 4.Which region accounts for the largest insomnia market share?
  • 5.Which are the leading companies in the global insomnia market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Insomnia Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Therapy Type

  • 6.1 Non-Pharmacological Therapy
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Hypnotherapy
      • 6.1.2.2 Cognitive Behavioral Therapy
      • 6.1.2.3 Medical Devices
      • 6.1.2.4 Others
    • 6.1.3 Market Forecast
  • 6.2 Pharmacological Therapy
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Prescription Sleep Aids
      • 6.2.2.2 Over-The-Counter Sleep Aids
    • 6.2.3 Market Forecast

7 Market Breakup by Drug Class

  • 7.1 Antidepressants
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Melatonin Antagonist
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Benzodiazepines
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Nonbenzodiazepines
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Orexin Antagonist
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Drug Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Pharmacies
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Astellas Pharma Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Aurobindo Pharma Limited
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
    • 14.3.3 Biocodex
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Eisai Co. Ltd.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Mallinckrodt Pharmaceuticals
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
    • 14.3.6 Merck & Co. Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Neurim Pharmaceuticals Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Pfizer Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Sanofi S.A.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sumitomo Dainippon Pharma Co. Ltd. (Sumitomo Chemical Co. Ltd.)
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Takeda Pharmaceutical Company Limited
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Vanda Pharmaceuticals Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials

List of Figures

  • Figure 1: Global: Insomnia Market: Major Drivers and Challenges
  • Figure 2: Global: Insomnia Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Insomnia Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Insomnia Market: Breakup by Therapy Type (in %), 2024
  • Figure 5: Global: Insomnia Market: Breakup by Drug Class (in %), 2024
  • Figure 6: Global: Insomnia Market: Breakup by Distribution Channel (in %), 2024
  • Figure 7: Global: Insomnia Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Insomnia (Non-Pharmacological Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Insomnia (Non-Pharmacological Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Insomnia (Pharmacological Therapy) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Insomnia (Pharmacological Therapy) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Insomnia (Antidepressants) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Insomnia (Antidepressants) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Insomnia (Melatonin Antagonist) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Insomnia (Melatonin Antagonist) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Insomnia (Benzodiazepines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Insomnia (Benzodiazepines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Insomnia (Nonbenzodiazepines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Insomnia (Nonbenzodiazepines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Insomnia (Orexin Antagonist) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Insomnia (Orexin Antagonist) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Insomnia (Other Drug Classes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Insomnia (Other Drug Classes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Insomnia (Hospital Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Insomnia (Hospital Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Insomnia (Retail Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Insomnia (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Insomnia (Drug Stores) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Insomnia (Drug Stores) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Insomnia (Online Pharmacies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Insomnia (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: North America: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: North America: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: United States: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: United States: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Canada: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Canada: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Asia-Pacific: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Asia-Pacific: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: China: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: China: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: Japan: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: Japan: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: India: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: India: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: South Korea: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: South Korea: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Australia: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Australia: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Indonesia: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Indonesia: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Others: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Others: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Europe: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Europe: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Germany: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Germany: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: France: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: France: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: United Kingdom: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: United Kingdom: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Italy: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Italy: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Spain: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Spain: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Russia: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Russia: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Others: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Others: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Latin America: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Latin America: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Brazil: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Brazil: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Mexico: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Mexico: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Others: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Others: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Middle East and Africa: Insomnia Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Middle East and Africa: Insomnia Market: Breakup by Country (in %), 2024
  • Figure 80: Middle East and Africa: Insomnia Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Global: Insomnia Industry: SWOT Analysis
  • Figure 82: Global: Insomnia Industry: Value Chain Analysis
  • Figure 83: Global: Insomnia Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Insomnia Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Insomnia Market Forecast: Breakup by Therapy Type (in Million USD), 2025-2033
  • Table 3: Global: Insomnia Market Forecast: Breakup by Drug Class (in Million USD), 2025-2033
  • Table 4: Global: Insomnia Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 5: Global: Insomnia Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Insomnia Market: Competitive Structure
  • Table 7: Global: Insomnia Market: Key Players